TOGETHER WE CAN MAKE A DIFFERENCE
Hunter is battling Charcot-Marie-Tooth Disease Type 4B3 (CMT4B3), a rare and progressive neuromuscular disorder. Right now, there are no cures or treatments available. But together, we can drive the discovery of life-changing breakthroughs for Hunter and thousands of children living with early onset nerve diseases.
When Hunter’s parents, Iris and Brett Schultz, were told that CMT4B3 would eventually rob their son of his mobility—and possibly his sight and hearing—they refused to accept that fate. Determined to find answers, they founded Hunters CMT4B3 Research Foundation with a single mission: to save their son and countless others affected by CMT4B3 and related neuromuscular diseases.
CMT affects 1 in every 2,500 people—an estimated 150,000 in the U.S. and 3 million worldwide. That’s as many as those affected by Multiple Sclerosis (MS), and more than those living with ALS (Lou Gehrig’s Disease).
We can’t do it alone. Your donation will directly fund groundbreaking research in labs working to discover treatments for CMT4B3. Together, we can bring hope to those who need it most.
